Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin-induced Ototoxicity”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Not applicableUnknownNCT01285674
What this trial is testing

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Who this might be right for
CisplatinOtotoxicityIntratympanic Steroids
Ziv Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05129748
What this trial is testing

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 92
Testing effectiveness (Phase 2)Ended earlyNCT02281006
What this trial is testing

Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity

Who this might be right for
DDPHead and Neck CancerAdverse Effect
CHU de Quebec-Universite Laval 13
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Very early researchTemporarily pausedNCT05756660
What this trial is testing

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Who this might be right for
Ototoxicity, Drug-Induced
Children's Hospital Medical Center, Cincinnati 33
Not applicableUnknownNCT00578760
What this trial is testing

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Who this might be right for
Hearing LossOtotoxicity
University Health Network, Toronto 110
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Testing effectiveness (Phase 2)UnknownNCT01451853
What this trial is testing

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Who this might be right for
Lung CancerHead and Neck CancerHearing Loss+3 more
Sound Pharmaceuticals, Incorporated 80
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Not applicableStudy completedNCT02099786
What this trial is testing

Randomized Trial Comparison of Ototoxicity Monitoring Programs

Who this might be right for
Cisplatin OtotoxicityHearing Loss
VA Office of Research and Development 47
Early research (Phase 1)Study completedNCT04262336
What this trial is testing

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Who this might be right for
Ototoxicity
Decibel Therapeutics 22
Testing effectiveness (Phase 2)Study completedNCT05628233
What this trial is testing

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Who this might be right for
Hearing Loss Ototoxic
Sensorion 48
Not applicableWithdrawnNCT02382068
What this trial is testing

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Who this might be right for
Malignant NeoplasmOtotoxicity
Aaron Moberly
Load More Results